Coronary Functional Assessment in Non-obstructive Coronary Artery Disease: Present Situation and Future Direction
Overview
Affiliations
Non-obstructive coronary artery disease (CAD), which is defined as coronary stenosis <50%, has been increasingly recognized as an emerging entity in clinical practice. Vasomotion abnormality and coronary microvascular dysfunction are two major mechanisms contributing to the occur of angina with non-obstructive CAD. Although routine coronary functional assessment is limited due to several disadvantages, functional evaluation can help to understand the pathophysiological mechanism and/or to exclude specific etiologies. In this review, we summarized the potential mechanisms involved in ischemia with non-obstructive coronary arteries (INOCA) and myocardial infarction with non-obstructive coronary arteries (MINOCA), the two major form of non-obstructive CAD. Additionally, we reviewed currently available functional assessment indices and their use in non-obstructive CAD. Furthermore, we speculated that novel technique combined anatomic and physiologic parameters might provide more individualized therapeutic choice for patients with non-obstructive CAD.
Tudurachi A, Anghel L, Tudurachi B, Zavoi A, Ceasovschih A, Sascau R J Clin Med. 2024; 13(16).
PMID: 39200755 PMC: 11354865. DOI: 10.3390/jcm13164613.
Chemokine Fractalkine and Non-Obstructive Coronary Artery Disease-Is There a Link?.
Stangret A, Sadowski K, Jablonski K, Kochman J, Opolski G, Grabowski M Int J Mol Sci. 2024; 25(7).
PMID: 38612695 PMC: 11012077. DOI: 10.3390/ijms25073885.
Klemenc M, Budihna G, Kranjec I Eur Heart J Case Rep. 2024; 8(1):ytad605.
PMID: 38173781 PMC: 10762887. DOI: 10.1093/ehjcr/ytad605.
Avtaar Singh S, Nappi F Biomedicines. 2022; 10(12).
PMID: 36551766 PMC: 9775403. DOI: 10.3390/biomedicines10123010.